Lopinavir and ritonavir

FDA Drug Profile — Lopinavir and ritonavir

Lopinavir and ritonavir is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Lopinavir and ritonavir. Available dosage form: tablet, film coated.

Drug details

Generic Name
Lopinavir and ritonavir
Brand Names
Lopinavir and ritonavir
Application Number
ANDA091677
Sponsor
Camber Pharmaceuticals, Inc.
NDC Codes
2
Dosage Forms
TABLET, FILM COATED
Routes
ORAL
Active Ingredients
LOPINAVIR, RITONAVIR

Indications and Usage

1 INDICATIONS AND USAGE Lopinavir and ritonavir is indicated in combination with other antiretroviral agents for the treatment of HIV1 infection in adults and pediatric patients 14 days and older. Limitations of Use: Genotypic or phenotypic testing and/or treatment history should guide the use of lopinavir and ritonavir. The number of baseline lopinavir resistance-associated substitutions affects the virologic response to lopinavir and ritonavir [see Microbiology ( 12.4 )]. Lopinavir and ritonavir is an HIV-1 protease inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients (14 days and older). ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.